3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow Infectious Disease: new trials by email Literature Review of Infectious Disease trials Research Report on Infectious Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| University of Utah COVID-19 Hydrochloroquine Trial Hydroxychloroquine, Placebo oral tablet - Coronavirus Infection, Coronavirus | Phase 2 | Completed | University of Utah | 368 | 2020-04-04 | 2023-02-15 |
| Phase 2, Multiple Ascending Dose Proof of Concept Study CMX157, TDF - Infectious Disease | Phase 2 | Completed | ContraVir Pharmaceuticals, Inc. | 62 | 2016-05-01 | 2017-09-13 |
| Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients P128-0.1 mg, P128-0.3 mg, P128-1.0 mg - Infectious Disease, Bacterial Infections | Phase 1 / Phase 2 | Completed | GangaGen, Inc. | 74 | 2012-12-01 | 2016-03-07 |
Communicable Diseases (3) · Bacterial Infections (1) · COVID-19 (1) · Coronavirus Infections (1) · Hepatitis B, Chronic (1)
Disease Attributes (3) · Infections (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Virus Diseases (2) · Bacterial Infections and Mycoses (1) · Blood-Borne Infections (1) · Chronic Disease (1) · Coronaviridae Infections (1) · DNA Virus Infections (1) · Digestive System Diseases (1) · Hepadnaviridae Infections (1) · Hepatitis (1) · Hepatitis B (1) · Hepatitis, Chronic (1)
Hydroxychloroquine (1) · hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine (1)
ContraVir Pharmaceuticals, Inc. (1) · GangaGen, Inc. (1) · University of Utah (1)
Singapore (1) · Thailand (1) · United States (1)
Adam Spivak, MD (1) · Dale A Fisher, MBBS, FRACP (1) · John Sullivan-Boylai, MD (1) · Surinder Kher, MD (1)